As healthcare professionals, we often encounter patients presenting with acute chest pain, a symptom that requires urgent and careful assessment due to its potential life-threatening implications. This article aims to provide a comprehensive guide to the clinical approach and management of such cases.
The initial evaluation of acute chest pain involves a thorough history taking and physical examination. The clinician should focus on the character, onset, location, duration, and radiation of the pain. Associated symptoms such as shortness of breath, nausea, and diaphoresis can suggest a cardiac etiology.
Diagnostic testing is paramount in the evaluation of acute chest pain. An electrocardiogram (ECG) should be obtained immediately to identify ST-elevation myocardial infarction (STEMI). Serial cardiac biomarkers, chest x-ray, and echocardiogram can further assist in the diagnosis.
Risk stratification using tools such as the HEART score aids in determining the appropriate disposition of the patient. This score incorporates History, ECG, Age, Risk factors, and Troponin levels to predict major adverse cardiac events.
Management strategies depend on the underlying cause of the chest pain. In cases of suspected acute coronary syndrome (ACS), initial management includes aspirin, nitroglycerin, and possibly anticoagulation. Refractory cases may require invasive strategies such as percutaneous coronary intervention (PCI).
Acute chest pain is a common but challenging presentation in clinical practice. A structured approach involving thorough history taking, appropriate diagnostic testing, risk stratification, and tailored management can ensure optimal patient outcomes. Continual education and staying abreast with current guidelines are crucial for healthcare professionals dealing with such cases.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation